Literature DB >> 21197608

SEEG-guided RF-thermocoagulation of epileptic foci: a therapeutic alternative for drug-resistant non-operable partial epilepsies.

M Guénot1, J Isnard, H Catenoix, F Mauguière, M Sindou.   

Abstract

BACKGROUND: Previous literature includes numerous reports of acute stereotactic ablation for epilepsy. Most reports focus on amygdalotomies or amygdalohippocampotomies, some others focus on various extra-limbic targets. These stereotactic techniques proved to have a less favourable outcome than that of standard surgery, so that their rather disappointing benefit/risk ratio explains why they have been largely abandoned. However, depth electrode recordings may be required in some cases of epilepsy surgery to delineate the best region of cortical resection. We usually implant depth electrodes according to Talairach's stereo electroencephalography (SEEG) methodology. Using these chronically implanted depth electrodes, we are able to perform radiofrequency (RF)-thermolesions of the epileptic foci. This paper reports the technical data required to perform such multiple cortical thermolesions, as well as the results in terms of seizure outcome in a group of 41 patients. TECHNICAL DATA: Lesions are placed in the cortex areas showing either a low amplitude fast pattern or spike-wave discharges at the onset of the seizures. Interictal paroxysmal activities are not considered for planning thermocoagulation sites. All targets are first functionally evaluated using electrical stimulation. Only those showing no clinical response to stimulation are selected for thermolesion, including sites located inside or near primary functional area. Lesions are performed using 120mA bipolar current (50 V), applied for 10-30 sec. Each thermocoagulation produces a 5-7mm diameter cortical lesion. A total of 2-31 lesions were performed in each of the 41 patients. Lesions are placed without anaesthesia.
RESULTS: 20 patients (48.7%) experienced a seizure frequency decrease of at least 50% that was more than 80% in eight of them. One patient was seizure free after RF thermocoagulation. In 21 patients, no significant reduction of the seizure frequency was observed. Amongst the characteristics of the disease (age and sex of the patient, lobar localization of the EZ) and the characteristics of the thermocoagulations (topography, lateralization, number, morphology of the lesions on MRI) no factor was significantly linked to the outcome. However, the best results were clearly observed in epilepsies symptomatic of a cortical development malformation (CDM), with 67% of responders in this group of 20 patients (p = 0.052). Three transient post-procedure side-effects, consisting of paraesthetic sensations in the mouth (2 cases), and mild apraxia of the hand, were observed.
CONCLUSION: SEEG-guided-RF-thermolesioning is a safe technique. Our results indicate that such lesions can lead to a significant reduction of seizure frequency. Our experience suggests that SEEG-guided RF thermocoagulation should be dedicated to drug-resistant epileptic patients for whom conventional resection surgery is risky or contra-indicated on the basis of invasive pre-surgical evaluation, particularly those suffering from epilepsy symptomatic of cortical development malformation.

Entities:  

Mesh:

Year:  2011        PMID: 21197608     DOI: 10.1007/978-3-7091-0179-7_4

Source DB:  PubMed          Journal:  Adv Tech Stand Neurosurg        ISSN: 0095-4829


  10 in total

1.  [New aspects in the field of epilepsy].

Authors:  F Rosenow; K M Klein; A Strzelczyk; H M Hamer; K Menzler; S Bauer; S Knake
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 2.  [Stereotactic laser thermocoagulation in epilepsy surgery].

Authors:  C Hoppe; J-A Witt; C Helmstaedter; T Gasser; H Vatter; C E Elger
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

3.  Three-dimensional skeletonization and symbolic description in vascular imaging: preliminary results.

Authors:  L Verscheure; L Peyrodie; A S Dewalle; N Reyns; N Betrouni; S Mordon; M Vermandel
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-07-31       Impact factor: 2.924

Review 4.  Optimized stereoelectroencephalography-guided radiofrequency thermocoagulation in the treatment of patients with focal epilepsy.

Authors:  Di Wang; Penghu Wei; Yongzhi Shan; Liankun Ren; Yuping Wang; Guoguang Zhao
Journal:  Ann Transl Med       Date:  2020-01

5.  Improving recorded volume in mesial temporal lobe by optimizing stereotactic intracranial electrode implantation planning.

Authors:  R Zelmann; S Beriault; M M Marinho; K Mok; J A Hall; N Guizard; C Haegelen; A Olivier; G B Pike; D L Collins
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-03-26       Impact factor: 2.924

6.  In-vivo measurements of human brain tissue conductivity using focal electrical current injection through intracerebral multicontact electrodes.

Authors:  Laurent Koessler; Sophie Colnat-Coulbois; Thierry Cecchin; Janis Hofmanis; Jacek P Dmochowski; Anthony M Norcia; Louis G Maillard
Journal:  Hum Brain Mapp       Date:  2016-10-11       Impact factor: 5.038

Review 7.  Seizure outcomes in nonresective epilepsy surgery: an update.

Authors:  Dario J Englot; Harjus Birk; Edward F Chang
Journal:  Neurosurg Rev       Date:  2016-05-21       Impact factor: 3.042

Review 8.  MRI-guided stereotactic amygdalohippocampectomy: a single center experience.

Authors:  Zdeněk Vojtěch; Hana Malíková; Lenka Krámská; Roman Liščák; Vilibald Vladyka
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-11       Impact factor: 2.570

Review 9.  Advances in epilepsy surgery.

Authors:  Mark Nowell; Anna Miserocchi; Andrew W McEvoy; John S Duncan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-09       Impact factor: 10.154

10.  Multiple Stereoelectroencephalography-Guided Radiofrequency Thermocoagulations for Polymicrogyria With Startle Seizures: A Case Report.

Authors:  Yi'Ou Liu; Wenjing Zhou; Bo Hong; Tong Zhao; Chengwei Xu; Jing Ruan; Jianjun Bai; Siyu Wang
Journal:  Front Neurol       Date:  2019-10-18       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.